Cargando…

Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8(+) T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatocellular carcinoma is a kind of tumor with a high malignant degree and mortality rate, and there is no effective treatment method. Currently, immunotherapy has shown good prospects in treating hepatocellular carcinoma. As an important approach of immunotherapy, the vaccine has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Yanyan, Lu, Zheng, Ding, Jiage, Jiang, Nan, Wang, Jiawei, Yang, Jie, Song, Jingyuan, Chen, Hongliang, Fang, Lin, Li, Huizhong, Tian, Hui, Wang, Gang, Zheng, Junnian, Chai, Dafei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497125/ https://www.ncbi.nlm.nih.gov/pubmed/36139670 http://dx.doi.org/10.3390/cancers14184512

Ejemplares similares

The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma
por: Jiang, Nan, et al.
Publicado: (2023)

HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8(+)T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma
por: Shi, Xiaoqing, et al.
Publicado: (2023)

Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity
por: Chai, Dafei, et al.
Publicado: (2021)

Recombinant oncolytic adenovirus armed with CCL5, IL-12, and IFN-γ promotes CAR-T infiltration and proliferation in vivo to eradicate local and distal tumors
por: Fang, Lin, et al.
Publicado: (2023)

Co‐immunization with L‐Myc enhances CD8(+) or CD103(+) DCs mediated tumor‐specific multi‐functional CD8(+) T cell responses
por: Chai, Dafei, et al.
Publicado: (2021)

Absent in melanoma 2 enhances anti‐tumour effects of CAIX promotor controlled conditionally replicative adenovirus in renal cancer
por: Chai, Dafei, et al.
Publicado: (2020)

H1/pAIM2 nanoparticles exert anti‐tumour effects that is associated with the inflammasome activation in renal carcinoma
por: Chai, Dafei, et al.
Publicado: (2018)

iNKT: A new avenue for CAR-based cancer immunotherapy
por: Liu, Yilin, et al.
Publicado: (2022)

Complement C1q binding protein regulates T cells’ mitochondrial fitness to affect their survival, proliferation, and anti–tumor immune function
por: Tian, Hui, et al.
Publicado: (2022)

The optimization system for preparation of TG1 competent cells and electrotransformation
por: Chai, Dafei, et al.
Publicado: (2020)

C1QBP regulates mitochondrial plasticity to impact tumor progression and antitumor immune response
por: Wang, Qiping, et al.
Publicado: (2022)

IFI35 Promotes Renal Cancer Progression by Inhibiting pSTAT1/pSTAT6-Dependent Autophagy
por: Chai, Dafei, et al.
Publicado: (2022)

The Anti-fibrosis drug Pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-β
por: Wang, Gang, et al.
Publicado: (2022)

Tumor-Penetrating Peptide Enhances Antitumor Effects of IL-24 Against Prostate Cancer
por: Yang, Jie, et al.
Publicado: (2018)

ISG12a and its interaction partner NR4A1 are involved in TRAIL‐induced apoptosis in hepatoma cells
por: Liu, Nianli, et al.
Publicado: (2019)

Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma
por: Zhang, Qing, et al.
Publicado: (2017)

Absent in melanoma 2-mediating M1 macrophages facilitate tumor rejection in renal carcinoma
por: Chai, Dafei, et al.
Publicado: (2021)

The development of CAR design for tumor CAR-T cell therapy
por: Xu, Dandan, et al.
Publicado: (2018)

Reassembling of albumin-bound paclitaxel mitigates myelosuppression and improves its antitumoral efficacy via neutrophil-mediated targeting drug delivery
por: Chen, Yuxin, et al.
Publicado: (2022)

B7-H3 specific CAR-T cells exhibit potent activity against prostate cancer
por: Li, Shibao, et al.
Publicado: (2023)

Corrigendum to “Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models”
por: Zhang, Qing, et al.
Publicado: (2019)

Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
por: Zhang, Qing, et al.
Publicado: (2018)

Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL
por: Huang, Jing-Hua, et al.
Publicado: (2009)

Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ(2) or IL-18Rα
por: Choi, I-K, et al.
Publicado: (2011)

Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ(2) or IL-18Rα
por: Choi, I-K, et al.
Publicado: (2011)

Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma
por: Wang, Cong-Jun, et al.
Publicado: (2012)

Manipulation of Mitochondrial Plasticity Changes the Metabolic Competition Between “Foe” and “Friend” During Tumor Malignant Transformation
por: Tian, Hui, et al.
Publicado: (2020)

The nuclear translocation of transketolase inhibits the farnesoid receptor expression by promoting the binding of HDAC3 to FXR promoter in hepatocellular carcinoma cell lines
por: Li, Minle, et al.
Publicado: (2020)

Post-translational modifications of EZH2 in cancer
por: Li, Zhongwei, et al.
Publicado: (2020)

Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF
por: Zhang, Song-Nan, et al.
Publicado: (2011)

Role of CD28/B7 costimulation and IL-12/IL-10 interaction in the radiation-induced immune changes
por: Liu, Shu-Zheng, et al.
Publicado: (2001)

Regulation of Antitumor Immune Responses by the IL-12 Family Cytokines, IL-12, IL-23, and IL-27
por: Xu, Mingli, et al.
Publicado: (2010)

New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model
por: Limbach, Keith, et al.
Publicado: (2017)

Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients
por: Butterfield, Lisa H, et al.
Publicado: (2014)

A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGD
por: Zhang, Qing, et al.
Publicado: (2015)

Human Adenovirus Associated Hepatic Injury
por: Zheng, Nan, et al.
Publicado: (2022)

Combination of oncolytic adenovirus targeting SATB1 and docetaxel for the treatment of castration-resistant prostate cancer
por: Mao, Lijun, et al.
Publicado: (2021)

Immune status affects the clinical features and outcomes of adult patients with respiratory adenovirus infection
por: Zhao, Handan, et al.
Publicado: (2021)

Survival prediction and response to immune checkpoint inhibitors: A prognostic immune signature for hepatocellular carcinoma
por: Xu, Ying, et al.
Publicado: (2020)

Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors
por: Su, Yinghan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0melohp9i0553roi1k32i6nmv4